Mother-daughter HPV vaccine study in Kenya
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at giving HPV vaccines to mothers and daughters in Kenya. It tests whether community meetings help more families get the vaccine, which can prevent cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women must be aged 25 to 49 years and willing to join group talks.
- Women cannot be pregnant during the study.
- Girls must be aged 9 to 14 years.
- Girls need a mother who can sign a consent form for the vaccine.
- Girls must be able to come back for a second HPV vaccine shot 6 to 12 months later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called 5-fluorouracil (5FU) after a procedure called thermal ablation helps clear HPV better than ablation alone. The study is for women with HIV in Kenya who have an HPV infection.
This study tests a mobile health tool (an app) and related surveys to improve knowledge and screening awareness for cervical cancer, including HPV risk and acceptability. It involves people working in cervical cancer screening and women in specific communities, with participation based on consent and eligibility for screening.
This study aims to make cervical cancer screening easier and more patient-friendly for women in Kenya. If you are a woman between 25 and 49, not pregnant or recently postpartum, you may be able to join.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
This study tests whether a single dose of the HPV vaccine (Gardasil 9) can reduce HPV infection and transmission in women. It might help prevent cervical cancer and other HPV-related conditions.
This study looks at how HPV vaccines are given to girls in Ethiopia, aiming to improve access and uptake. It involves interviews and surveys with girls and their caregivers.
Hear when a new Cervical Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.